Your browser doesn't support javascript.
loading
The Cost-Effectiveness Analysis of Transplant-Ineligible Myeloma Patients with Bortezomib plus Thalidomide plus Dexamethasone (VTD) or Bortezomib plus Melphalan plus Prednisolone (VMP) Treatment in Southern Taiwan.
Du, Jeng-Shiun; Kuo, Yi-Chun; Shi, Hon-Yi; Wang, Ming-Chung; Wang, Li-Ying; Chuang, Tzer-Ming; Ke, Ya-Lun; Yeh, Tsung-Jang; Gau, Yu-Ching; Wang, Hui-Ching; Cho, Shih-Feng; Hsiao, Samuel Yien; Liu, Yi-Chang; Hsu, Chin-Mu; Hsiao, Hui-Hua.
Afiliación
  • Du JS; Division of Hematology and Oncology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan.
  • Kuo YC; Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
  • Shi HY; Master of Science in Healthcare Administration, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
  • Wang MC; Department of Healthcare Administration and Medical Informatics, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
  • Wang LY; Division of Hematology-Oncology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 807, Taiwan.
  • Chuang TM; Division of Hematology-Oncology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 807, Taiwan.
  • Ke YL; Division of Hematology and Oncology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan.
  • Yeh TJ; Division of Hematology and Oncology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan.
  • Gau YC; Division of Hematology and Oncology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan.
  • Wang HC; Division of Hematology-Oncology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 807, Taiwan.
  • Cho SF; Division of Hematology and Oncology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan.
  • Hsiao SY; Division of Hematology-Oncology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 807, Taiwan.
  • Liu YC; Division of Hematology and Oncology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan.
  • Hsu CM; Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
  • Hsiao HH; Faculty of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
J Pers Med ; 12(2)2022 Jan 19.
Article en En | MEDLINE | ID: mdl-35207619

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Health_economic_evaluation Idioma: En Revista: J Pers Med Año: 2022 Tipo del documento: Article País de afiliación: Taiwán

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Health_economic_evaluation Idioma: En Revista: J Pers Med Año: 2022 Tipo del documento: Article País de afiliación: Taiwán